JFNCX
Price
$60.13
Change
-$0.44 (-0.73%)
Updated
Feb 21 closing price
Net Assets
5B
SHSAX
Price
$66.47
Change
-$0.42 (-0.63%)
Updated
Feb 21 closing price
Net Assets
7.43B
Ad is loading...

JFNCX vs SHSAX

Header iconJFNCX vs SHSAX Comparison
Open Charts JFNCX vs SHSAXBanner chart's image
Janus Henderson Global Life Sciences C
Price$60.13
Change-$0.44 (-0.73%)
VolumeN/A
Net Assets5B
BlackRock Health Sciences Opps Inv A
Price$66.47
Change-$0.42 (-0.63%)
VolumeN/A
Net Assets7.43B
JFNCX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNCX vs. SHSAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNCX is a Buy and SHSAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 7.44B vs. JFNCX (5B). SHSAX pays higher dividends than JFNCX: SHSAX (0.23) vs JFNCX (0.00). JFNCX was incepted earlier than SHSAX: JFNCX (16 years) vs SHSAX (25 years). JFNCX is a more actively managed with annual turnover of: 34.00 vs. SHSAX (29.00). SHSAX has a lower initial minimum investment than JFNCX: SHSAX (1000) vs JFNCX (2500). JFNCX annual gain was more profitable for investors over the last year : -5.43 vs. SHSAX (-5.83). JFNCX return over 5 years is better than : 8.39 vs. SHSAX (0.57).
JFNCXSHSAXJFNCX / SHSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years25 years-
Gain YTD5.2886.45482%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets5B7.44B67%
Annual Yield % from dividends0.000.23-
Returns for 1 year-5.43-5.8393%
Returns for 3 years11.001.011,095%
Returns for 5 years8.390.571,483%
Returns for 10 years10.7928.1738%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEKCX16.950.10
+0.59%
DWS Emerging Markets Equity C
DBOYX24.02-0.30
-1.23%
BNY Mellon Balanced Opportunity Y
PABVX15.57-0.29
-1.83%
Principal MidCap Value I R5
VEVIX46.53-0.88
-1.86%
Victory Sycamore Established Value I
GSCTX12.84-0.33
-2.51%
Goldman Sachs Small Cp Val Insghts C